SOLY News and Press, Soliton Inc. From 08/13/20

HOUSTON , Aug. 13, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced it has completed the design process for an advanced handpiece and cartridge for its Rapi...

Soliton, Inc. (SOLY) Q2 2020 Results Earnings Conference Call August 11, 2020, 8:30 AM ET Company Participants Carol Ruth - Founder and President, The Ruth Group, Investor Relations Wally Klemp - Co-Founder and Executive Chairman Chris Capelli - Co-Founder, Chief Executive and Sc...

Soliton (NASDAQ: SOLY ) : Q2 GAAP EPS of -$0.19 in-line. More news on: Soliton, Inc., Earnings news and commentary, , Read more ...

HOUSTON , Aug. 11, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial results for the second quarter ended June 30, 2020 . Recent Company Highl...

HOUSTON , Aug. 5, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Dr. Sachin Shridharani to its Scientific Advisory Board, effect...

HOUSTON , July 29, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, announced today that it will report its second quarter 2020 financial results and provide a business update on Tu...

HOUSTON , July 22, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced Dr. Elizabeth Tanzi , lead investigator on Soliton's pivotal cellulite clinical tr...

HOUSTON , July 21, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today provided an update regarding the U.S. commercialization of its Rapid Acoustic Pulse device in...

The following slide deck was published by Soliton, Inc. in conjunction with this Read more ...

HOUSTON , July 15, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced that its 510(k) application for premarket clearance filed with the U.S. Food and Dr...